Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark
Autor: | Christine Merrild Posselt, Merete Nordentoft, Carsten Hjorthøj |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
Male Marijuana Abuse Adolescent Denmark Poison control Comorbidity Young Adult Injury prevention Medicine Humans Longitudinal Studies Registries Prospective cohort study Aged Aged 80 and over biology business.industry Hazard ratio Middle Aged biology.organism_classification medicine.disease Psychiatry and Mental health Schizophrenia Attributable risk Female Cannabis business General Economics Econometrics and Finance Demography Diagnosis of schizophrenia |
Zdroj: | JAMA psychiatry. 78(9) |
ISSN: | 2168-6238 |
Popis: | Importance Cannabis use and potency of cannabis have increased during the past 2 decades. If the association between cannabis use and schizophrenia is causal, this should be reflected in an increase in the proportion of cases of schizophrenia being attributable to cannabis, the population-attributable risk fraction (PARF). Objective To determine whether the PARF for cannabis use disorder in schizophrenia has increased over time. Design, setting, and participants This nationwide, register-based historical prospective cohort study included all people in Denmark born before December 31, 2000, who were alive and 16 years or older at some point from January 1, 1972, to December 31, 2016. Data analysis was performed from August 2020 to April 2021. Exposure Diagnosis of cannabis use disorder. Main outcomes and measures Diagnosis of schizophrenia, with estimated PARF of cannabis use disorder in schizophrenia from 1972 to 2016. Results A total of 7 186 834 individuals were included in the analysis, including 3 595 910 women (50.0%) and 3 590 924 men (50.0%). The adjusted hazard ratio for schizophrenia fluctuated at approximately 4 (with 95% CIs ranging from approximately 3 to 6) throughout most of the study period when people diagnosed with cannabis use disorder were compared with those without cannabis use disorder. The PARF of cannabis use disorder in schizophrenia also fluctuated, but with clear evidence of an increase from 1995 (when the PARF was relatively stable around 2.0%, with a 95% CI of approximately 0.3% to either side) until reaching some stability around 6.0% to 8.0% (with a 95% CI of approximately 0.5% to either side) since 2010. Conclusions and relevance The results from these longitudinal analyses show the proportion of cases of schizophrenia associated with cannabis use disorder has increased 3- to 4-fold during the past 2 decades, which is expected given previously described increases in the use and potency of cannabis. This finding has important ramifications regarding legalization and control of use of cannabis. |
Databáze: | OpenAIRE |
Externí odkaz: |